2 Real-world results tell a more nuanced story
January 2, 2025: More People File Ozempic Lawsuits Ahead of 2025 As of January 2, 2025, there are 1,331 pending lawsuits against GLP-1 drug manufacturers as part of federal, consolidated litigation
Studies suggest that MSM may have a supportive effect on osteoarthritis, particularly regarding pain, stiffness, and swelling
Tirzepatide : The latest advancement in GLP-1 agonist therapy, Tirzepatide combines the benefits of GLP-1 with GIP (glucose-dependent insulinotropic polypeptide), another hormone involved in blood sugar regulation
Suspected side effects can be reported directly to the MHRA through the Yellow Card scheme at www.mhra.gov.uk/yellowcard